Oscar Health, Inc. filed a Form 8-K with the SEC on September 16, 2026, disclosing updated full-year 2026 financial guidance presented at its 2026 Investor Day.
Key Highlights
- Medical Loss Ratio guidance improved: Oscar updated its MLR range to between 81.0% and 82.0%, an improvement of 50 basis points from its previous expectation of 81.5% to 82.5%.
- Earnings from Operations raised: The company increased its full-year 2026 Earnings from Operations guidance to between $600 million and $800 million, up $100 million from the prior range of $500 million to $700 million.
- Total Revenue guidance reaffirmed: Oscar reaffirmed its full-year 2026 Total Revenue guidance of between $18.7 billion and $19.0 billion.
- SG&A Expense Ratio reaffirmed: The company also reaffirmed its SG&A Expense Ratio guidance of between 15.6% and 16.1%.
- Investor Day held September 16, 2026: The event began at 9:00 a.m. Eastern Time, with strategy and long-term financial targets discussed alongside the updated guidance.
Oscar Health Raises Earnings and MLR Guidance at 2026 Investor Day
According to the filing, Oscar Health, Inc. (NYSE:OSCR) hosted its 2026 Investor Day on September 16, 2026, beginning at 9:00 a.m. Eastern Time. At the event, the company disclosed improvements to two components of its full-year 2026 financial guidance while reaffirming two others, under Item 7.01 (Regulation FD Disclosure).
The filing states that Oscar updated its Medical Loss Ratio guidance to a range of 81.0% to 82.0%, which the company described as "an improvement of 50 basis points from its previous expectation of 81.5% to 82.5%." Additionally, the company raised its Earnings from Operations guidance range to between $600 million and $800 million, "an increase of $100 million from its previous expectation of $500 million to $700 million," according to the filing.
Oscar also reaffirmed its full-year 2026 Total Revenue guidance of between $18.7 billion and $19.0 billion, as well as its SG&A Expense Ratio guidance of between 15.6% and 16.1%. The filing notes that a live webcast of the presentation and associated materials was made available on Oscar's investor relations website at ir.oscarhealth.com, and the webcast is to be archived for 90 days following September 16, 2026. The filing includes the company's cautionary note that all forward-looking statements are subject to risks and uncertainties and are not guarantees of future performance.
What Was Disclosed
Oscar Health filed an 8-K on September 16, 2026, disclosing updated and reaffirmed full-year 2026 guidance items presented at its Investor Day, including improved MLR and Earnings from Operations ranges and reaffirmed Total Revenue and SG&A Expense Ratio ranges.




Please wait processing your request...